A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies

por Benepal, T, Jackman, A, Pyle, L, Bate, S, Hardcastle, A, Aherne, W, Mitchell, F, Simmons, L, Ruddle, R, Raynaud, F, Gore, M
Publicado 2005

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has...

por Varey, A H R, Rennel, E S, Qiu, Y, Bevan, H S, Perrin, R M, Raffy, S, Dixon, A R, Paraskeva, C, Zaccheo, O, Hassan, A B, Harper, S J, Bates, D O
Publicado 2008

Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma

por Park, S R, Kim, H K, Kim, C G, Choi, I J, Lee, J S, Lee, J H, Ryu, K W, Kim, Y-W, Bae, J-M, Kim, N K
Publicado 2008

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients

por Allegrini, G, Falcone, A, Fioravanti, A, Barletta, M T, Orlandi, P, Loupakis, F, Cerri, E, Masi, G, Di Paolo, A, Kerbel, R S, Danesi, R, Del Tacca, M, Bocci, G
Publicado 2008

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours

por Siegel-Lakhai, W S, Zandvliet, A S, Huitema, A D R, Tibben, M M, Milano, G, Girre, V, Diéras, V, King, A, Richmond, E, Wanders, J, Beijnen, J H, Schellens, J H M
Publicado 2008

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using...

por Julka, P K, Chacko, R T, Nag, S, Parshad, R, Nair, A, Oh, D S, Hu, Z, Koppiker, C B, Nair, S, Dawar, R, Dhindsa, N, Miller, I D, Ma, D, Lin, B, Awasthy, B, Perou, C M
Publicado 2008

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

por Sobrero, A, Frassineti, G, Falcone, A, Dogliotti, L, Rosso, R, Costanzo, F D, Bruzzi, P
Publicado 2005

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer

por Ryan, B, O'Donovan, N, Browne, B, O'Shea, C, Crown, J, Hill, A D K, McDermott, E, O'Higgins, N, Duffy, M J
Publicado 2005

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the th...

por Máximo, V, Botelho, T, Capela, J, Soares, P, Lima, J, Taveira, A, Amaro, T, Barbosa, A P, Preto, A, Harach, H R, Williams, D, Sobrinho-Simões, M
Publicado 2005

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

por Uziel, O, Fenig, E, Nordenberg, J, Beery, E, Reshef, H, Sandbank, J, Birenbaum, M, Bakhanashvili, M, Yerushalmi, R, Luria, D, Lahav, M
Publicado 2005

Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial

por Lorenzen, S, Duyster, J, Lersch, C, von Delius, S, Hennig, M, Bredenkamp, R, Peschel, C, Lordick, F
Publicado 2005

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma

por Gemmill, R M, Zhou, M, Costa, L, Korch, C, Bukowski, R M, Drabkin, H A
Publicado 2005

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

por Riddick, A C P, Shukla, C J, Pennington, C J, Bass, R, Nuttall, R K, Hogan, A, Sethia, K K, Ellis, V, Collins, A T, Maitland, N J, Ball, R Y, Edwards, D R
Publicado 2005

Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline

por Yates, C, Wells, A, Turner, T
Publicado 2005

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

por Loi, S, Ngan, S Y K, Hicks, R J, Mukesh, B, Mitchell, P, Michael, M, Zalcberg, J, Leong, T, Lim-Joon, D, Mackay, J, Rischin, D
Publicado 2005

Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile

por Giovannetti, E, Mey, V, Danesi, R, Basolo, F, Barachini, S, Deri, M, Del Tacca, M
Publicado 2005

Specific fatty acid intake and the risk of pancreatic cancer in Canada

por Nkondjock, A, Krewski, D, Johnson, K C, Ghadirian, P
Publicado 2005

Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions

por Prokopchuk, O, Liu, Y, Henne-Bruns, D, Kornmann, M
Publicado 2005

Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas

por Bernini, G P, Moretti, A, Oriandini, C, Bardini, M, Taurino, C, Salvetti, A
Publicado 2005

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene

por Maier, C, Haeusler, J, Herkommer, K, Vesovic, Z, Hoegel, J, Vogel, W, Paiss, T
Publicado 2005